Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Rectal Neoplasms 1 Pain, Postoperative 1 Obesity 1 Inflammation 1 Ileus 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Colonic Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

Exercise 25 Metformin 23 Tirzepatide 9 Resistance Training 8 Nutrition Assessment 8 Methods 8 Diet Therapy 8 Diet 8 Counseling 8 Surveys and Questionnaires 6 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Liraglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Therapeutics 3 Tamoxifen 3 Sugars 3 Standard of Care 3 Observation 3 Naltrexone 3 Letrozole 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Ketorolac × Other × Clear all

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡